Non-small cell lung cancer, version 5.2017

Clinical practice guidelines in oncology

David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica Bauman, Lucian R. Chirieac, Thomas A. D'Amico, Malcolm M. Decamp, Thomas J. Dilling, Michael Dobelbower, Robert C. Doebele, Ramaswamy Govindan, Matthew A. Gubens, Mark Hennon, Leora Horn, Ritsuko Komaki, Rudy P. Lackner, Michael Lanuti, Ticiana A. Leal, Leah J. Leisch & 15 others Rogerio Lilenbaum, Jules Lin, Billy W. Loo, Renato Martins, Gregory A. Otterson, Karen Reckamp, Gregory J. Riely, Steven E. Schild, Theresa A. Shapiro, James Stevenson, Scott J. Swanson, Kurt Tauer, Stephen C. Yang, Kristina Gregory, Miranda Hughes

Research output: Contribution to journalReview article

342 Citations (Scopus)

Abstract

This selection from the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) focuses on targeted therapies and immunotherapies for metastatic NSCLC, because therapeutic recommendations are rapidly changing for metastatic disease. For example, new recommendations were added for atezolizumab, ceritinib, osimertinib, and pembrolizumab for the 2017 updates.

Original languageEnglish (US)
Pages (from-to)504-535
Number of pages32
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume15
Issue number4
StatePublished - Apr 1 2017

Fingerprint

Practice Guidelines
Non-Small Cell Lung Carcinoma
Immunotherapy
Guidelines
Therapeutics
pembrolizumab
osimertinib
ceritinib
MPDL3280A

ASJC Scopus subject areas

  • Oncology

Cite this

Ettinger, D. S., Wood, D. E., Aisner, D. L., Akerley, W., Bauman, J., Chirieac, L. R., ... Hughes, M. (2017). Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 15(4), 504-535.

Non-small cell lung cancer, version 5.2017 : Clinical practice guidelines in oncology. / Ettinger, David S.; Wood, Douglas E.; Aisner, Dara L.; Akerley, Wallace; Bauman, Jessica; Chirieac, Lucian R.; D'Amico, Thomas A.; Decamp, Malcolm M.; Dilling, Thomas J.; Dobelbower, Michael; Doebele, Robert C.; Govindan, Ramaswamy; Gubens, Matthew A.; Hennon, Mark; Horn, Leora; Komaki, Ritsuko; Lackner, Rudy P.; Lanuti, Michael; Leal, Ticiana A.; Leisch, Leah J.; Lilenbaum, Rogerio; Lin, Jules; Loo, Billy W.; Martins, Renato; Otterson, Gregory A.; Reckamp, Karen; Riely, Gregory J.; Schild, Steven E.; Shapiro, Theresa A.; Stevenson, James; Swanson, Scott J.; Tauer, Kurt; Yang, Stephen C.; Gregory, Kristina; Hughes, Miranda.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 15, No. 4, 01.04.2017, p. 504-535.

Research output: Contribution to journalReview article

Ettinger, DS, Wood, DE, Aisner, DL, Akerley, W, Bauman, J, Chirieac, LR, D'Amico, TA, Decamp, MM, Dilling, TJ, Dobelbower, M, Doebele, RC, Govindan, R, Gubens, MA, Hennon, M, Horn, L, Komaki, R, Lackner, RP, Lanuti, M, Leal, TA, Leisch, LJ, Lilenbaum, R, Lin, J, Loo, BW, Martins, R, Otterson, GA, Reckamp, K, Riely, GJ, Schild, SE, Shapiro, TA, Stevenson, J, Swanson, SJ, Tauer, K, Yang, SC, Gregory, K & Hughes, M 2017, 'Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 15, no. 4, pp. 504-535.
Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman J, Chirieac LR et al. Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network. 2017 Apr 1;15(4):504-535.
Ettinger, David S. ; Wood, Douglas E. ; Aisner, Dara L. ; Akerley, Wallace ; Bauman, Jessica ; Chirieac, Lucian R. ; D'Amico, Thomas A. ; Decamp, Malcolm M. ; Dilling, Thomas J. ; Dobelbower, Michael ; Doebele, Robert C. ; Govindan, Ramaswamy ; Gubens, Matthew A. ; Hennon, Mark ; Horn, Leora ; Komaki, Ritsuko ; Lackner, Rudy P. ; Lanuti, Michael ; Leal, Ticiana A. ; Leisch, Leah J. ; Lilenbaum, Rogerio ; Lin, Jules ; Loo, Billy W. ; Martins, Renato ; Otterson, Gregory A. ; Reckamp, Karen ; Riely, Gregory J. ; Schild, Steven E. ; Shapiro, Theresa A. ; Stevenson, James ; Swanson, Scott J. ; Tauer, Kurt ; Yang, Stephen C. ; Gregory, Kristina ; Hughes, Miranda. / Non-small cell lung cancer, version 5.2017 : Clinical practice guidelines in oncology. In: JNCCN Journal of the National Comprehensive Cancer Network. 2017 ; Vol. 15, No. 4. pp. 504-535.
@article{c1f4f4ead5c447e5a90c9f54e2353aaf,
title = "Non-small cell lung cancer, version 5.2017: Clinical practice guidelines in oncology",
abstract = "This selection from the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) focuses on targeted therapies and immunotherapies for metastatic NSCLC, because therapeutic recommendations are rapidly changing for metastatic disease. For example, new recommendations were added for atezolizumab, ceritinib, osimertinib, and pembrolizumab for the 2017 updates.",
author = "Ettinger, {David S.} and Wood, {Douglas E.} and Aisner, {Dara L.} and Wallace Akerley and Jessica Bauman and Chirieac, {Lucian R.} and D'Amico, {Thomas A.} and Decamp, {Malcolm M.} and Dilling, {Thomas J.} and Michael Dobelbower and Doebele, {Robert C.} and Ramaswamy Govindan and Gubens, {Matthew A.} and Mark Hennon and Leora Horn and Ritsuko Komaki and Lackner, {Rudy P.} and Michael Lanuti and Leal, {Ticiana A.} and Leisch, {Leah J.} and Rogerio Lilenbaum and Jules Lin and Loo, {Billy W.} and Renato Martins and Otterson, {Gregory A.} and Karen Reckamp and Riely, {Gregory J.} and Schild, {Steven E.} and Shapiro, {Theresa A.} and James Stevenson and Swanson, {Scott J.} and Kurt Tauer and Yang, {Stephen C.} and Kristina Gregory and Miranda Hughes",
year = "2017",
month = "4",
day = "1",
language = "English (US)",
volume = "15",
pages = "504--535",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "4",

}

TY - JOUR

T1 - Non-small cell lung cancer, version 5.2017

T2 - Clinical practice guidelines in oncology

AU - Ettinger, David S.

AU - Wood, Douglas E.

AU - Aisner, Dara L.

AU - Akerley, Wallace

AU - Bauman, Jessica

AU - Chirieac, Lucian R.

AU - D'Amico, Thomas A.

AU - Decamp, Malcolm M.

AU - Dilling, Thomas J.

AU - Dobelbower, Michael

AU - Doebele, Robert C.

AU - Govindan, Ramaswamy

AU - Gubens, Matthew A.

AU - Hennon, Mark

AU - Horn, Leora

AU - Komaki, Ritsuko

AU - Lackner, Rudy P.

AU - Lanuti, Michael

AU - Leal, Ticiana A.

AU - Leisch, Leah J.

AU - Lilenbaum, Rogerio

AU - Lin, Jules

AU - Loo, Billy W.

AU - Martins, Renato

AU - Otterson, Gregory A.

AU - Reckamp, Karen

AU - Riely, Gregory J.

AU - Schild, Steven E.

AU - Shapiro, Theresa A.

AU - Stevenson, James

AU - Swanson, Scott J.

AU - Tauer, Kurt

AU - Yang, Stephen C.

AU - Gregory, Kristina

AU - Hughes, Miranda

PY - 2017/4/1

Y1 - 2017/4/1

N2 - This selection from the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) focuses on targeted therapies and immunotherapies for metastatic NSCLC, because therapeutic recommendations are rapidly changing for metastatic disease. For example, new recommendations were added for atezolizumab, ceritinib, osimertinib, and pembrolizumab for the 2017 updates.

AB - This selection from the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) focuses on targeted therapies and immunotherapies for metastatic NSCLC, because therapeutic recommendations are rapidly changing for metastatic disease. For example, new recommendations were added for atezolizumab, ceritinib, osimertinib, and pembrolizumab for the 2017 updates.

UR - http://www.scopus.com/inward/record.url?scp=85017563403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017563403&partnerID=8YFLogxK

M3 - Review article

VL - 15

SP - 504

EP - 535

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 4

ER -